Profound Medical (TSE:PRN) Shares Down 0.2% – Should You Sell?

Shares of Profound Medical Corp. (TSE:PRN) traded down 0.2% on Tuesday . The company traded as low as C$10.30 and last traded at C$10.30. 9,329 shares traded hands during trading, an increase of 33% from the average session volume of 7,004 shares. The stock had previously closed at C$10.32.

Profound Medical Price Performance

The firm has a market cap of C$244.31 million, a price-to-earnings ratio of -6.03 and a beta of 0.81. The business’s 50-day moving average price is C$11.22 and its two-hundred day moving average price is C$11.56. The company has a debt-to-equity ratio of 16.95, a current ratio of 8.61 and a quick ratio of 14.98.

Profound Medical (TSE:PRN) last released its quarterly earnings data on Thursday, August 8th. The company reported C($0.38) EPS for the quarter, hitting analysts’ consensus estimates of C($0.38). The business had revenue of C$3.06 million during the quarter, compared to analyst estimates of C$3.42 million. On average, research analysts forecast that Profound Medical Corp. will post -1.9000001 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Senior Officer Rashed Osman Dewan purchased 9,765 shares of Profound Medical stock in a transaction dated Thursday, August 15th. The stock was bought at an average price of C$12.85 per share, with a total value of C$125,480.25. 8.62% of the stock is currently owned by corporate insiders.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.